In Portrait | The Investor Network
The Business Angels Club Berlin-Brandenburg has been supporting startup founders in building their own companies for more than 20 years.
Start-ups Meet Pharma: take up the challenge
Deadline: September 26, 2025
Interview | Prof. Dr. Petra Ritter, Head of the “Brain Simulation Section” at the Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin
European test infrastructure for AI in healthcare
BiotechBikers Berlin Ride
Meeting Point: Byron Bar, in front of the Bayer Campus in Berlin
WHO and Charité launch new visiting fellowship in public health intelligence
The Charité Center for Global Health and the WHO Hub for Pandemic and Epidemic Intelligence, both based in Berlin, Germany, have launched a visiting fellowship to strengthen research in public health intelligence.
4C Accelerator - Medical Innovations Incubator
Deadline: Monday July 7th, 2025
S100A1 Identified as Potential New Biomarker for Frailty in Older Patients with Heart Disease
Frailty is a condition characterized by increased vulnerability and decline in physical function. It is a growing concern in the aging population, particularly among those with heart disease. A multidisciplinary research team led by the German…
Tumor diagnostics: AI model detects more than 170 types of cancer
The MRI image shows a brain tumor in an inauspicious location, – and a brain biopsy will entail high risks for the patient, who had consulted us due to double vision. Situations such as this case discussion, cited by way of example, in a…
Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany
Eckert & Ziegler (ISIN DE0005659700, TecDAX) congratulates Telix Pharmaceuticals Limited (Telix) on the approval of its prostate cancer PET imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide injection) in Germany, where Eckert…